This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: W. L. Gore & Associates, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Michael C. Chan: Innovator in Bioabsorbable Medical Devices
Introduction
Michael C. Chan is a notable inventor based in Flagstaff, AZ (US). He has made significant contributions to the field of medical technology, particularly in the development of bioabsorbable medical devices. His innovative work focuses on creating solutions that enhance patient care and improve medical outcomes.
Latest Patents
Michael C. Chan holds a patent for bioabsorbable medical devices. This patent encompasses various aspects of apparatuses, systems, and methods that include a plurality of absorbable filaments arranged in a support structure. These filaments are designed to degrade within a defined time period. Additionally, the invention features a membrane that surrounds the absorbable filaments, which is configured to contain fragments of the filaments in response to a fracture or degradation.
Career Highlights
Michael C. Chan is associated with W. L. Gore & Associates, Inc., where he has been instrumental in advancing medical device technology. His work has led to the development of innovative products that address critical healthcare needs. With a focus on bioabsorbable materials, he has contributed to the evolution of medical devices that are both effective and safe for patients.
Collaborations
Some of his notable coworkers include Edward H. Cully and Jeffrey B. Duncan. Their collaborative efforts have further enhanced the research and development of medical technologies at W. L. Gore & Associates, Inc.
Conclusion
Michael C. Chan's contributions to the field of bioabsorbable medical devices exemplify his commitment to innovation in healthcare. His work not only advances medical technology but also significantly impacts patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile